SCIENCE IN SPORT PLC

Major Shareholding Notification • Oct 14, 2022

National Storage Mechanism | Additional information

RNS Number : 9929C

Science in Sport PLC

14 October 2022

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser:	Science in Sport plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):      The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:      Use a separate form for each offeror/offeree	Science in Sport plc
(d) Is the discloser the offeror or the offeree?	OFFEREE
(e) Date position held:      The latest practicable date prior to the disclosure	13 October 2022
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?      If it is a cash offer or possible cash offer, state "N/A"	No

2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Class of relevant security:
	Interests		Short positions
Number	%	Number	%
(1) Relevant securities owned and/or controlled:
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b)        Rights to subscribe for new securities

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Name of director	Number of Science in Sport plc ordinary shares held	Percentage of total issued share capital
John Clarke	313,635	0.23
Stephen Moon	924,537	0.66
Daniel Lampard (incoming CFO)	nil	nil
Tim Wright	156,823	0.11
Roger Mather	106,790	0.08

Rights to subscribe for new securities

Stephen Moon and Daniel Lampard agreed to subscribe for 221,574 and 33,333 shares respectively at a price of 15p in Science in Sport Plc on 30 September 2022

Options held by directors of Science in Sport plc in Science in Sport plc ordinary shares

Name of director	Grant date	Number of Science in Sport plc ordinary shares in which options granted	Exercise price	Earliest exercise date	Expiry Date
John Clarke	22 March 2016	221,360	nil	22 March 2016	21 March 2026
John Clarke	26 Sept 2016	327,273	nil	22 March 2019	25 Sept 2026
Stephen Moon	22 July 2014	328,125	nil	22 July 2014	21 July 2024
Stephen Moon	26 March 2015	267,206	nil	25 March 2015	25 March 2025
Stephen Moon	22 March 2016	1,089,675	nil	22 March 2016	21 March 2026
Stephen Moon	26 Sept 2016	1,460,356	nil	22 March 2019	25 Sept 2026
Stephen Moon	22 March 2017	623,721	nil	22 March 2017	21 March 2027
Stephen Moon	22 March 2017	460,164	nil	22 March 2018	21 March 2027
Stephen Moon	21 March 2018	81,806	nil	21 March 2018	20 March 2027
Stephen Moon	20 March 2019	780,769	nil	20 March 2019	20 March 2029
Stephen Moon	1 October 2020	1,108,070	nil	1 October 2020	1 October 2030
Stephen Moon	1 October 2020	1,555,612	nil	1 April 2022	1 April 2032

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
None

(c)        Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)	NO
Supplemental Form 8 (SBL)	NO

###### Date of disclosure:	13 October 2022
###### Contact name:	Stephen Moon
###### Telephone number:	02074003700

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RETFFLFLLEESEES